Trial
NCT06171178
A Study of ASP1012 in Adults With Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
—
Condition
Solid Tumor
Intervention
ASP1012
Why stopped
Due to strategic decision made by the sponsor the study was terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-29